4//SEC Filing
PRASAD SUYASH 4
Accession 0001209191-20-052116
CIK 0001806310other
Filed
Sep 24, 8:00 PM ET
Accepted
Sep 25, 5:14 PM ET
Size
5.0 KB
Accession
0001209191-20-052116
Insider Transaction Report
Form 4
PRASAD SUYASH
CMO and Head of R&D
Transactions
- Award
Common Stock
2020-09-23+668,745→ 668,745 total
Footnotes (2)
- [F1]The shares underlying the RSU vest in 4 equal annual installments on each of June 29, 2021, June 29, 2022, June 29, 2023 and June 29, 2024, subject to the Reporting Person's continuous service as of each such vesting date
- [F2]Each RSU represents a contingent right to receive one share the Issuer's common stock.
Documents
Issuer
Taysha Gene Therapies, Inc.
CIK 0001806310
Entity typeother
Related Parties
1- filerCIK 0001679129
Filing Metadata
- Form type
- 4
- Filed
- Sep 24, 8:00 PM ET
- Accepted
- Sep 25, 5:14 PM ET
- Size
- 5.0 KB